ly2157299
Ly2157299 is a drug used to treat Glioma, Hepatocellular Carcinoma, Healthy Volunteers, and other conditions. Ly2157299 is being actively studied in 3 studies and prior, has been studied in 7.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Eli Lilly and Company | For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. | |
| Providence Health & Services | Northwestern University | |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559 ) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Active, not recruiting
- Rectal Adenocarcinoma
- LY2157299
- +3 more
- Portland, OregonProvidence Cancer Center
2022-03-22
Mar 22, 2022S
Recruiting
- Prostate Cancer
- Enzalutamide
- LY2157299
- Washington, District of Columbia
- +3 more
2022-01-18
Jan 18, 2022E
E
E
Completed
- Hepatocellular Carcinoma
- LY2157299
- +2 more
- Beijing, China
- +15 more
2022-02-14
Feb 14, 2022E
Completed
- Carcinoma, Hepatocellular
- LY2157299
- +2 more
- Fayetteville, Arkansas
- +39 more
2020-12-21
Dec 21, 2020E
Completed
- Glioma
- LY2157299
- +2 more
- La Jolla, California
- +9 more
2017-02-15
Feb 15, 2017E
E
Completed
- Neoplasms
- Neoplasm Metastasis
- LY2157299
- Tokyo, JapanFor additional information regarding investigative sites for thi
2014-06-30
Jun 30, 2014E
Completed
- Healthy Volunteers
- LY2157299
- Daytona Beach, FloridaFor additional information regarding investigative sites for thi
2013-12-03
Dec 3, 2013